Deutsche Bank AG Invests $1.28 Million in Encompass Health Corporation $EHC

Key Points

• Deutsche Bank acquired 12,716 shares of Encompass Health in the second quarter, valued at approximately $1.285 million. Institutional investors collectively own 97.25% of the company.
• Encompass Health exceeded quarterly expectations, reporting $1.55 in EPS on $1.60 billion in revenue, with revenue up 9.6% year over year. The company issued fiscal 2026 EPS guidance of $6.02–$6.25.
• The company raised its quarterly dividend from $0.19 to $0.21 per share, while analysts maintained a bullish outlook with an average “Buy” rating and a $148.71 price target.

Deutsche Bank AG purchased a new stake in Encompass Health Corporation (NYSE:EHC - Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,716 shares of the company's stock, valued at approximately $1,285,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in EHC. Persistent Asset Partners Ltd acquired a new stake in shares of Encompass Health in the 2nd quarter worth $36,000. Assetmark Inc. boosted its position in shares of Encompass Health by 89.6% during the 1st quarter. Assetmark Inc. now owns 455 shares of the company's stock valued at $44,000 after acquiring an additional 215 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in shares of Encompass Health by 36,200.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company's stock valued at $46,000 after purchasing an additional 362 shares during the period. Aster Capital Management DIFC Ltd purchased a new stake in shares of Encompass Health in the fourth quarter valued at about $55,000. Finally, Harbor Investment Advisory LLC acquired a new stake in Encompass Health during the second quarter worth about $56,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Trading Up 1.2%

Shares of EHC stock opened at $120.98 on Friday. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99. The firm has a market cap of $11.93 billion, a PE ratio of 19.70, a price-to-earnings-growth ratio of 2.45 and a beta of 0.72. The company has a 50-day moving average of $113.20 and a two-hundred day moving average of $107.18. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.19.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.48 by $0.07. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The business's revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, analysts predict that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. This is a positive change from Encompass Health's previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. Encompass Health's payout ratio is currently 12.38%.

Insider Buying and Selling at Encompass Health

In related news, EVP John Patrick Darby sold 8,906 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the transaction, the executive vice president owned 75,041 shares of the company's stock, valued at approximately $9,451,413.95. This represents a 10.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Mark J. Tarr sold 173,148 shares of the firm's stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total value of $21,724,879.56. Following the transaction, the chief executive officer owned 267,814 shares of the company's stock, valued at $33,602,622.58. This trade represents a 39.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.80% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Truist Financial lifted their target price on shares of Encompass Health from $140.00 to $150.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. UBS Group raised their price target on shares of Encompass Health from $150.00 to $155.00 and gave the stock a "buy" rating in a report on Friday, August 7th. Weiss Ratings raised shares of Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, August 12th. Wall Street Zen upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Sunday, August 16th. Finally, TD Cowen increased their price objective on Encompass Health from $125.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Encompass Health presently has an average rating of "Buy" and an average price target of $148.71.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.